Charité - Universitätsmedizin Berlin - Klinik für Pädiatrie m.S. Pneumologie, Immunologie und Intensivmedizin
Die Charité – Universitätsmedizin Berlin ist eine gemeinsame Einrichtung der Freien Universität Berlin und der Humboldt-Universität zu Berlin. Sie hat als eines der größten Universitätsklinika Europas mit bedeutender Geschichte eine führende Rolle in Forschung, Lehre und Krankenversorgung inne. Aber auch als modernes Unternehmen mit Zertifizierungen im medizinischen, klinischen und im Management-Bereich tritt die Charité hervor.
Working field:
The DFG-funded Collaborative Research Center (CRC 1449) "Dynamic Hydrogels at Biointerfaces" hosted by the Freie Universität Berlin comprises a series of theoretical and experimental projects, which aim for the identification and elucidation of physicochemical properties of biological hydrogels (such as mucus and the glycocalyx) that define the protective function of such hydrogels.
The project
We are seeking a highly motivated and committed doctoral candidate for a research project that addresses the role of the airway mucins Muc5ac and Muc5b in the pathogenesis and as a therapeutic target of interstitial lung disease (ILD) using a novel mouse model recently established in the group (Duerr J, et al. Nat Commun. 2020). A better understanding of the composition, structure and function of the mucus hydrogel layer on airway surfaces is key to elucidate the underlying disease mechanism and to identify potential therapeutic targets for the development of new therapies for ILD.
The project is integrated in the Collaborative Research Centre (CRC) / Sonderforschungsbereich (SFB) 1449 “Dynamic Hydrogels at Biointerfaces”, where several research groups investigate key physicochemical and biophysical parameters that determine hydrogel function at biological interfaces in health and disease for prospective development of novel therapeutic strategies.
Requirements:
What we offer:
The scholarship will be supervised by Dr. Julia Duerr and Prof. Marcus Mall at Charité – Universitätsmedizin Berlin, deputy spokesperson of the CRC 1449. The group’s main focus is the investigation of the disease mechanisms and the development of new therapeutic strategies for chronic lung diseases such as ILD and cystic fibrosis (CF) (
https://www.bihealth.org/en/research/research-groups/marcus-mall). Furthermore, the awardees will become member of the CRC’s integrated Research Training Group, which offers:
How to apply:
We are looking forward to your application, which should contain the following documents:
Candidates have to meet the requirements, which would qualify them for entry to a doctoral program at the Charité – Universitätsmedizin Berlin. Students will be chosen on the basis of their previous grades and academic references. The CRC 1449 encourages, in particular, women as well as disabled persons to apply for the scholarships.
Awardees will receive a stipend of € 1.365 per month. An additional material cost allowance of € 103 per month will also be paid. A child care allowance may be granted if applicable. Please visit
http://www.sfb1449.de for further information.
Applications should be addressed via email until 07/31/2022 to the coordinator of the CRC’s integrated Research Training Group:
irtg@sfb1449.de. Please send all documents in a single PDF file and refer to the identifier sfb1449_scholarship_ILD in your email.